Compounded tirzepatide
GobyMeds vs OurView Health
Quick answer
OurView Health costs $131 a real month and GobyMeds costs $145 — a difference of $14 a month, or $164 a year. Both figures are computed from what each seller actually charges and how often, not from the price on its landing page.
What each one bills
| GobyMeds | OurView Health | |
|---|---|---|
| True monthly cost | $145 | $131 |
| Advertised as | $133 | $119 |
| Charged | every 12 weeks | every 30 days |
| Each charge | $399 | $129 |
| Price basis | a starting-dose price that climbs | the same at every dose |
| Mandatory recurring fee | none found | none found |
| States it names | not published | not published |
| FDA warning letter | none on record | none on record |
Where they actually differ
- They bill on different clocks. GobyMeds charges every 12 weeks and OurView Health charges every 30 days. That alone changes what a “month” costs, which is the whole reason this index recomputes every price.
- One price holds and the other climbs. GobyMeds’s price is a starting-dose price that climbs; OurView Health’s is the same at every dose. See what titration does to an advertised figure.
- What they advertise is not what they bill. GobyMeds advertises $133 and bills $145; OurView Health advertises $119 and bills $131.
How we know
Both figures were read on the seller’s own site and recomputed over a 30.4375-day calendar month from the charge and the billing period it covers. Neither is a seller’s own “/mo”. The full working for each — the charge, the period, the arithmetic and the date it was read — is on its own page: GobyMeds and OurView Health. The method is set out in how we verify.
To compare any two sellers in the index rather than these two, use the comparison tool.